NIVF logo

NewGenIvf Group NasdaqGM:NIVF Stock Report

Last Price

US$0.26

Market Cap

US$3.7m

7D

-4.4%

1Y

-97.6%

Updated

30 Jan, 2025

Data

Company Financials

NewGenIvf Group Limited

NasdaqGM:NIVF Stock Report

Market Cap: US$3.7m

NIVF Stock Overview

Provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan. More details

NIVF fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

NewGenIvf Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for NewGenIvf Group
Historical stock prices
Current Share PriceUS$0.26
52 Week HighUS$17.24
52 Week LowUS$0.24
Beta-0.24
1 Month Change-36.05%
3 Month Change-65.05%
1 Year Change-97.64%
3 Year Changen/a
5 Year Changen/a
Change since IPO-97.37%

Recent News & Updates

Recent updates

Shareholder Returns

NIVFUS HealthcareUS Market
7D-4.4%2.2%-0.5%
1Y-97.6%0.3%24.3%

Return vs Industry: NIVF underperformed the US Healthcare industry which returned -0.1% over the past year.

Return vs Market: NIVF underperformed the US Market which returned 25.2% over the past year.

Price Volatility

Is NIVF's price volatile compared to industry and market?
NIVF volatility
NIVF Average Weekly Movement24.1%
Healthcare Industry Average Movement7.8%
Market Average Movement6.5%
10% most volatile stocks in US Market18.8%
10% least volatile stocks in US Market3.3%

Stable Share Price: NIVF's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: NIVF's weekly volatility has decreased from 38% to 24% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
201070Alfred Siunewgenivf.com

NewGenIvf Group Limited provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan. Its services includes mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, mrt techniques, in-vitro fertilization /ICSI, hysteroscopy, semen analysis, TESE/TESA/PESA, embryo transfer, egg freezing, and chromosome screening, as well as surrogacy and ancillary caring services. The company was founded in 2010 and is based in Central, Hong Kong.

NewGenIvf Group Limited Fundamentals Summary

How do NewGenIvf Group's earnings and revenue compare to its market cap?
NIVF fundamental statistics
Market capUS$3.66m
Earnings (TTM)-US$80.77k
Revenue (TTM)US$5.68m

0.6x

P/S Ratio

-43.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NIVF income statement (TTM)
RevenueUS$5.68m
Cost of RevenueUS$4.19m
Gross ProfitUS$1.48m
Other ExpensesUS$1.57m
Earnings-US$80.77k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0059
Gross Margin26.14%
Net Profit Margin-1.42%
Debt/Equity Ratio-85.7%

How did NIVF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 14:45
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NewGenIvf Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution